Literature DB >> 16920814

Small cytoplasmic domain peptides of natriuretic peptide receptor-C attenuate cell proliferation through Gialpha protein/MAP kinase/PI3-kinase/AKT pathways.

Shehla Hashim1, Yuan Li, Madhu B Anand-Srivastava.   

Abstract

The present studies were undertaken to investigate the effect of C-atrial natriuretic peptide (ANP)(4-23) and several peptide fragments containing 12 amino acids from different regions of the cytoplasmic domain of natriuretic peptide receptor (NPR)-C on cell proliferation in the absence or presence of angiotensin (ANG) II, endothelin (ET)-1, and arginine vasopressin (AVP) in A-10 vascular smooth muscle cells (VSMC). The peptide fragments used have either complete G(i) activator sequences K(461)-H(472) (peptide 1) and H(481)-H(492) (peptide 3) or partial G(i) activator sequences R(469)-K(480) (peptide 2) and I(465)-H(472) (peptide Y) with truncated COOH or NH(2) terminus, respectively. The other peptide used had no structural specificity (Q(473)-K(480), peptide X) or was the scrambled peptide control for peptide 1 (peptide Z). ANG II, ET-1 and AVP significantly stimulated DNA synthesis in these cells as determined by [(3)H]thymidine incorporation that was inhibited by peptides 1, 2, and 3 and not by peptides X, Y, and Z in a concentration-dependent manner, with an apparent K(i) between 1 and 10 nM. In addition, C-ANP(4-23), which interacts with NPR-C, also inhibited DNA synthesis stimulated by vasoactive peptides; however, the inhibition elicited by C-ANP(4-23) was not additive with the inhibition elicited by peptide 1. On the other hand, basal DNA synthesis in these cells was not inhibited by C-ANP(4-23) or the peptide fragments. Furthermore, vasoactive peptide-induced stimulation of DNA synthesis was inhibited by PD-98059 and wortmannin, and this inhibition was potentiated by peptide 1. In addition, peptide 1 also inhibited vasoactive peptide-induced phosphorylation of ERK1/2 and AKT and enhanced expression of G(i)alpha proteins. These data suggest that C-ANP(4-23) and small peptide fragments containing 12 amino acids irrespective of the region of the cytoplasmic domain of NPR-C inhibit proliferative responses of vasoactive peptides through G(i)alpha protein and MAP kinase/phosphatidylinositol 3-kinase/AKT pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920814     DOI: 10.1152/ajpheart.00327.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  17 in total

Review 1.  Natriuretic peptide C receptor signalling in the heart and vasculature.

Authors:  Robert A Rose; Wayne R Giles
Journal:  J Physiol       Date:  2007-11-15       Impact factor: 5.182

Review 2.  Natriuretic peptides in cardiometabolic regulation and disease.

Authors:  Nora E Zois; Emil D Bartels; Ingrid Hunter; Birgitte S Kousholt; Lisbeth H Olsen; Jens P Goetze
Journal:  Nat Rev Cardiol       Date:  2014-05-13       Impact factor: 32.419

Review 3.  NPR-C: a component of the natriuretic peptide family with implications in human diseases.

Authors:  Speranza Rubattu; Sebastiano Sciarretta; Angelica Morriello; Camilla Calvieri; Allegra Battistoni; Massimo Volpe
Journal:  J Mol Med (Berl)       Date:  2010-06-19       Impact factor: 4.599

4.  Atrial natriuretic peptide inhibits angiotensin II-stimulated proliferation in fetal cardiomyocytes.

Authors:  P F O'Tierney; N N Chattergoon; S Louey; G D Giraud; K L Thornburg
Journal:  J Physiol       Date:  2010-06-02       Impact factor: 5.182

5.  Molecular Mechanism of Naringenin Against High-Glucose-Induced Vascular Smooth Muscle Cells Proliferation and Migration Based on Network Pharmacology and Transcriptomic Analyses.

Authors:  Wenjun He; Yanming Wang; Rui Yang; Huihui Ma; Xuqing Qin; Meijuan Yan; Yi Rong; Yufang Xie; Li Li; Junqiang Si; Xinzhi Li; Ketao Ma
Journal:  Front Pharmacol       Date:  2022-06-09       Impact factor: 5.988

6.  Natriuretic peptide receptor-C activation attenuates angiotensin II-induced enhanced oxidative stress and hyperproliferation of aortic vascular smooth muscle cells.

Authors:  Padma Madiraju; Ekhtear Hossain; Madhu B Anand-Srivastava
Journal:  Mol Cell Biochem       Date:  2018-02-07       Impact factor: 3.396

7.  Signal protein-derived peptides as functional probes and regulators of intracellular signaling.

Authors:  Alexander O Shpakov
Journal:  J Amino Acids       Date:  2011-08-23

8.  Natriuretic peptide receptor-C agonist attenuates the expression of cell cycle proteins and proliferation of vascular smooth muscle cells from spontaneously hypertensive rats: role of Gi proteins and MAPkinase/PI3kinase signaling.

Authors:  Jasmine El Andalousi; Yuan Li; Madhu B Anand-Srivastava
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

9.  Natriuretic peptide receptors regulate cytoprotective effects in a human ex vivo 3D/bioreactor model.

Authors:  Nicholas Peake; Nyan Su; Manoj Ramachandran; Pramod Achan; Donald M Salter; Dan L Bader; Amie J Moyes; Adrian J Hobbs; Tina T Chowdhury
Journal:  Arthritis Res Ther       Date:  2013-07-24       Impact factor: 5.156

10.  Atrial natriuretic peptide attenuates agonist-induced pulmonary edema in mice with targeted disruption of the gene for natriuretic peptide receptor-A.

Authors:  James R Klinger; Shu-Whei Tsai; Sabrina Green; Katie L Grinnell; Jason T Machan; Elizabeth O Harrington
Journal:  J Appl Physiol (1985)       Date:  2012-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.